Adapted emotional freedom techniques (EFT) for managing kinesiophobia in patients with rheumatoid arthritis: a feasibility study

针对类风湿性关节炎患者的运动恐惧症,采用改良的情绪释放疗法(EFT)进行管理:一项可行性研究

阅读:1

Abstract

BACKGROUND: Up to 70% of patients with rheumatoid arthritis (RA) experience kinesiophobia, a debilitating fear of movement that exacerbates physical limitations and psychological stress. However, effective interventions remain limited, particularly in resource-constrained settings. This study evaluated the feasibility, safety, and acceptability of an adapted Emotional Freedom Techniques (EFT) intervention for Chinese patients with RA. METHODS: A two-phase design was used. Phase 1 involved protocol validation and adaptation through the Delphi method. Phase 2 was a single-arm feasibility study involving 20 RA patients with kinesiophobia. The 4-week intervention included a 2-week supervised inpatient phase and a 2-week self-practice phase supported via WeChat. Feasibility (adherence, safety, satisfaction) and secondary outcomes (kinesiophobia, pain, pain anxiety, patient activation, and quality of life) were assessed. Data analysis included paired t-tests and thematic analysis of patient feedback. RESULTS: The adapted EFT protocol achieved expert consensus (I-CVI ≥ 0.80). Among participants, 80% met adherence criteria, no adverse events were reported, and 75-85% expressed satisfaction with the intervention. EFT was perceived as simple and accessible. Kinesiophobia scores decreased by 6.5 points (a 12.7% reduction; Hedges' g = 1.36), with moderate to large effects also seen for pain and anxiety. CONCLUSIONS: This adapted EFT intervention proved feasible, safe, and acceptable for Chinese RA patients with kinesiophobia. These findings support the potential for larger randomized controlled trials to rigorously evaluate effectiveness and long-term impact. CLINICAL TRIAL REGISTRATION: Chinese Clinical Trial Registry, ChiCTR2300076013. Date of registration: 21 September 2023.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。